Gadolinium is given to patients for magnetic resonance imaging, or an MRI.It is used as a contrast agent for the exam to improve clarity of the images formed. However, it can react in the human body and have detrimental effects. Therefore, the agent should be removed. One of these gadolinium based agents is gadodiamide. Calcium in the body should be determined accurately to ensure that the Gadodiamide does not have adverse effects on the patient. There are two o-cresolphthalein methods to determine amount of calcium. The o-cresolpthalein methods are effective because it is a calcium binding dye. The gadolinium ion with a charge of +3 can be removed from gadodiamide using o-cresolphthalein. For these methods, glomerular filtration rate, or GFR, and time since gadodiamide was given should be recorded. Ultimately, these two factors and the impact of gadodiamide on calcium levels calculated by the o-cresolphthalein method helps to reveal an amount of time that patients must wait after receiving gadodiamide to have blood drawn again, or avoid pseudohypocalcemia.